-
cell biology; cancer; cardiovascular; nutrition and diabetes; genetics; infection and immunology; imaging and biomedical engineering; transplantation immunology; pharmaceutical science; physiology and
-
expertise, including facilities for high-throughput screening and high content imaging, multimodality in vivo imaging, proteomics, spatial and single-cell transcriptomics. As part of King’s Health Partners
-
About Us The post will be based at St Thomas’ Hospital in central London in the School of Biomedical Engineering & Imaging Sciences at King’s College London: https://www.kcl.ac.uk/bmeis . There is
-
high content imaging, multimodality in vivo imaging, proteomics, spatial and single-cell transcriptomics. As part of King’s Health Partners, we have an excellent environment for basic-clinical
-
Formstone (see Panousopoulou et al. J. Cell Sci. 2016 (https://doi.org/10.1242/jcs.180703) and Prof. Philippa Francis-West (Mao et al. Nature Comms. 2016 (https://doi: 10.1038/ncomms11469 and Prof. Philippa
-
(https://www.kcl.ac.uk/research/photonics-nanotechnology ) involves the development and applications of advanced photonic technologies and of novel nanomaterials to address modern challenges in photonic
-
epidermis grow around the viscera. The work will be in close collaboration with Dr. Caroline Formstone (see Panousopoulou et al. J. Cell Sci. 2016 (https://doi.org/10.1242/jcs.180703) and Prof. Philippa
-
of Exeter. The research in Photonics & Nanotechnology Group (https://www.kcl.ac.uk/research/photonics-nanotechnology ) involves the development and applications of advanced photonic technologies and of novel
-
London and UK Catalysis Hub. The research in Photonics & Nanotechnology Group ( https://www.kcl.ac.uk/research/photonics-nanotechnology ) involves the development and applications of advanced photonic
-
Photonics & Nanotechnology Group ( https://www.kcl.ac.uk/research/photonics-nanotechnology ) involves the development and applications of advanced photonic technologies and of novel nanomaterials to address